OncoSec Announces Closing of 2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
ONCSDelisted Stock | USD 0.06 0 3.63% |
Slightly above 61% of OncoSec Medical's investor base is looking to short. The analysis of current outlook of investing in OncoSec Medical suggests that many traders are alarmed regarding OncoSec Medical's prospects. OncoSec Medical's investing sentiment can be driven by a variety of factors including economic data, OncoSec Medical's earnings reports, geopolitical events, and overall market trends.
OncoSec |
OncoSec Medical Incorporated , a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patients immune system to target cancer cells and eradicate disease, today announced the closing of its previously announced registered direct offering of 1,582,932 shares of its common stock, at a purchase price of 1.25 per share, priced at-the-market under Nasdaq rules. The Company also issued in a concurrent private placeme
Read at finance.yahoo.com
OncoSec Medical Fundamental Analysis
We analyze OncoSec Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoSec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoSec Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
OncoSec Medical is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
OncoSec Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OncoSec Medical stock to make a market-neutral strategy. Peer analysis of OncoSec Medical could also be used in its relative valuation, which is a method of valuing OncoSec Medical by comparing valuation metrics with similar companies.
Peers
OncoSec Medical Related Equities
ZVSA | ZyVersa Therapeutics | 4.23 | ||||
BDRX | Biodexa Pharmaceticals | 2.80 | ||||
ALLR | Allarity Therapeutics | 1.94 | ||||
VRAX | Virax Biolabs | 1.87 | ||||
UNCY | Unicycive Therapeutics | 1.64 | ||||
IMMX | Immix Biopharma | 0.97 | ||||
REVB | Revelation Biosciences | 2.44 | ||||
ATNF | 180 Life | 2.56 | ||||
QNRX | Quoin Pharmaceuticals | 3.39 | ||||
DRMA | Dermata Therapeutics | 4.32 | ||||
PHIO | Phio Pharmaceuticals | 10.47 | ||||
PALI | Palisade Bio | 10.84 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |